무선 심장 모니터링 시스템 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종사용자별, 지역별 및 부문별 예측(2026-2033년)

The global wireless cardiac monitoring systems market size was valued at USD 4.1 billion in 2025 and is projected to grow from USD 4.6 billion in 2026 to USD 9.7 billion by 2033, at a CAGR of 11.4% from 2026 to 2033. The North America dominated the market, accounting for a revenue share of 45.0% in 2025. Wireless cardiac monitoring systems are remote healthcare devices that track heart activity for medical analysis.

The market is expected to grow due to several factors, such as a growing geriatric population susceptible to cardiovascular diseases (CVDs), technological advancements in remote monitoring technologies, and increasing product approvals in developed economies. In 2025, the OECD reported that the proportion of individuals aged 65 years and older in the European Union increased from 18% in 2000 to 22% in 2024 and is projected to reach 29% by 2050. The report highlighted that population aging is expected to place greater pressure on healthcare systems and contribute to a substantial increase in the prevalence of cardiovascular diseases across Europe over the coming decades.

The advancements in remote patient monitoring technology are expected to boost the market. A growing number of industry players are entering into strategic alliances, such as funding and collaboration, to develop vendor-neutral cardiac data management platforms that allow companies to monitor medical information from implantable cardiac monitors (ICMs), wearable devices, consumer ECG devices, and other sources.

In addition, Technological advancements in remote patient monitoring and connected cardiac care platforms are expected to support market growth. Industry participants are increasingly investing in vendor-neutral cardiac data management systems that integrate data from implantable cardiac monitors, wearable devices, consumer ECG systems, and hospital-based monitoring solutions. The integration of artificial intelligence into these platforms is improving workflow efficiency through automated data analysis, prioritization of critical events, and enhanced clinical decision-making. For instance, in September 2025, Royal Philips partnered with Optum Healthcare to expand access to mobile cardiac telemetry (MCOT) and extended Holter monitoring solutions, supporting broader adoption of remote cardiac monitoring technologies and connected cardiac care services.

Global Wireless Cardiac Monitoring Systems Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented global wireless cardiac monitoring systems market report on the basis of type, end-use, and region.

Type (Revenue in USD Billion, 2021 - 2033)

• Implantable Cardiac Monitors (ICM)
• Patch-Type Monitor
• Mobile Cardiac Telemetry System
• Others

End-use (Revenue in USD Billion, 2021 - 2033)

• Hospitals & Clinics
• Diagnostic Centers
• Others
• Regional Outlook (Revenue in USD Billion 2021 - 2033)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Italy
• Spain
• Sweden
• Norway
• Denmark

Asia Pacific

• China
• Japan
• India
• Australia
• Thailand
• South Korea

Latin America

• Brazil
• Mexico
• Argentina

Middle East and Africa

• Saudi Arabia
• South Africa
• UAE
• Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Commodity Flow Analysis
    • 1.5.1.1. Approach 1: Commodity flow approach
• 1.6. Data Validation & Publishing
• 1.7. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Wireless Cardiac Monitoring Systems Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Rising geriatric population and increasing incidence of cardiovascular diseases
    • 3.3.1.2. Technological advancements in remote monitoring techniques
    • 3.3.1.3. Growing product approvals & provider facilities
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Inaccuracies with precision monitoring
    • 3.3.2.2. High dependence of selected geographic locations
• 3.4. Business Environment Analysis
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.4.2. Porter's Five Forces Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Wireless Cardiac Monitoring Systems Market: Type Business Analysis

• 4.1. Wireless Cardiac Monitoring Systems Market: Type Movement & Market Share Analysis, 2025 & 2033
• 4.2. Implantable Cardiac Monitors (ICM)
  • 4.2.1. Global Implantable Cardiac Monitors (ICM) Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.3. Patch-Type Monitor
  • 4.3.1. Global Patch-Type Monitor Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.4. Mobile Cardiac Telemetry Systems
  • 4.4.1. Global Mobile Cardiac Telemetry System Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.5. Others
  • 4.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Wireless Cardiac Monitoring Systems Market: End-Use Business Analysis

• 5.1. Wireless Cardiac Monitoring Systems Market: End-Use Movement & Market Share Analysis, 2025 & 2033
• 5.2. Hospitals & Clinics
  • 5.2.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.3. Diagnostic Centers
  • 5.3.1. Global Diagnostic Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.4. Others
  • 5.4.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Wireless Cardiac Monitoring Systems Market: Regional Business Analysis

• 6.1. Regional Market Snapshot
• 6.2. Market Share Analysis by Country, 2025
  • 6.2.1. North America
  • 6.2.2. Europe
  • 6.2.3. Asia Pacific
  • 6.2.4. Latin America
  • 6.2.5. MEA
• 6.3. North America
  • 6.3.1. North America Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
  • 6.3.2. U.S.
    • 6.3.2.1. U.S. Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.3.2.2. Key Country Dynamics
    • 6.3.2.3. Competitive Scenario
    • 6.3.2.4. Regulatory Framework
  • 6.3.3. Canada
    • 6.3.3.1. Canada Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.3.3.2. Key Country Dynamics
    • 6.3.3.3. Competitive Scenario
    • 6.3.3.4. Regulatory Framework
• 6.4. Europe
  • 6.4.1. Europe Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
  • 6.4.2. Germany
    • 6.4.2.1. Germany Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.2.2. Key Country Dynamics
    • 6.4.2.3. Competitive Scenario
    • 6.4.2.4. Regulatory Framework
  • 6.4.3. UK
    • 6.4.3.1. UK Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.3.2. Key Country Dynamics
    • 6.4.3.3. Competitive Scenario
    • 6.4.3.4. Regulatory Framework
  • 6.4.4. France
    • 6.4.4.1. France Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.4.2. Key Country Dynamics
    • 6.4.4.3. Competitive Scenario
    • 6.4.4.4. Regulatory Framework
  • 6.4.5. Italy
    • 6.4.5.1. Italy Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.5.2. Key Country Dynamics
    • 6.4.5.3. Competitive Scenario
    • 6.4.5.4. Regulatory Framework
  • 6.4.6. Spain
    • 6.4.6.1. Spain Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.6.2. Key Country Dynamics
    • 6.4.6.3. Competitive Scenario
    • 6.4.6.4. Regulatory Framework
  • 6.4.7. Denmark
    • 6.4.7.1. Denmark Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.7.2. Key Country Dynamics
    • 6.4.7.3. Competitive Scenario
    • 6.4.7.4. Regulatory Framework
  • 6.4.8. Sweden
    • 6.4.8.1. Sweden Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.8.2. Key Country Dynamics
    • 6.4.8.3. Competitive Scenario
    • 6.4.8.4. Regulatory Framework
    • 6.4.8.5.
  • 6.4.9. Norway
    • 6.4.9.1. Norway Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.4.9.2. Key Country Dynamics
    • 6.4.9.3. Competitive Scenario
    • 6.4.9.4. Regulatory Framework
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
  • 6.5.2. Japan
    • 6.5.2.1. Japan Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.5.2.2. Key Country Dynamics
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. Regulatory Framework
  • 6.5.3. China
    • 6.5.3.1. China Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.5.3.2. Key Country Dynamics
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Regulatory Framework
  • 6.5.4. India
    • 6.5.4.1. India Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.5.4.2. Key Country Dynamics
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Regulatory Framework
  • 6.5.5. South Korea
    • 6.5.5.1. South Korea Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.5.5.2. Key Country Dynamics
    • 6.5.5.3. Competitive Scenario
    • 6.5.5.4. Regulatory Framework
  • 6.5.6. Australia
    • 6.5.6.1. Australia Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.5.6.2. Key Country Dynamics
    • 6.5.6.3. Competitive Scenario
    • 6.5.6.4. Regulatory Framework
  • 6.5.7. Thailand
    • 6.5.7.1. Thailand Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.5.7.2. Key Country Dynamics
    • 6.5.7.3. Competitive Scenario
    • 6.5.7.4. Regulatory Framework
• 6.6. Latin America
  • 6.6.1. Latin America Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
  • 6.6.2. Brazil
    • 6.6.2.1. Brazil Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.6.2.2. Key Country Dynamics
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. Regulatory Framework
  • 6.6.3. Mexico
    • 6.6.3.1. Mexico Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.6.3.2. Key Country Dynamics
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Regulatory Framework
  • 6.6.4. Argentina
    • 6.6.4.1. Argentina Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.6.4.2. Key Country Dynamics
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. Regulatory Framework
• 6.7. MEA
  • 6.7.1. MEA Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
  • 6.7.2. South Africa
    • 6.7.2.1. South Africa Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.7.2.2. Key Country Dynamics
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. Regulatory Framework
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Saudi Arabia Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.7.3.2. Key Country Dynamics
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. Regulatory Framework
    • 6.7.3.5.
  • 6.7.4. UAE
    • 6.7.4.1. UAE Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.7.4.2. Key Country Dynamics
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Regulatory Framework
  • 6.7.5. Kuwait
    • 6.7.5.1. Kuwait Wireless Cardiac Monitoring Systems Market, 2021 - 2033 (USD Billion)
    • 6.7.5.2. Key Country Dynamics
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. Regulatory Framework

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
• 7.3. Company Profiles/Listing
  • 7.3.1. Koninklijke Philips N.V.
    • 7.3.1.1. Overview
    • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.1.3. Product Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Abbott
    • 7.3.2.1. Overview
    • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.2.3. Product Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. Medtronic
    • 7.3.3.1. Overview
    • 7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.3.3. Product Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. Biotronik SE & Co. KG
    • 7.3.4.1. Overview
    • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.4.3. Product Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. Boston Scientific Corporation
    • 7.3.5.1. Overview
    • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.5.3. Product Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Asahi Kasei Corporation.
    • 7.3.6.1. Overview
    • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.6.3. Product Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. iRhythm Technologies, Inc.
    • 7.3.7.1. Overview
    • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.7.3. Product Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Avertix Medical, Inc.
    • 7.3.8.1. Overview
    • 7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.8.3. Product Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. OSI Systems, Inc. (Spacelabs Healthcare)
    • 7.3.9.1. Overview
    • 7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.9.3. Product Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. Baxter International Inc.
    • 7.3.10.1. Overview
    • 7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.3.10.3. Product Benchmarking
    • 7.3.10.4. Strategic Initiatives